Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024
Emergent BioSolutions Inc. (NYSE: EBS) has announced it will host a conference call on August 6, 2024, at 5:00 pm eastern time to discuss its second quarter 2024 financial results. The call will cover key business updates, revenue guidance for the third quarter of 2024, and full year guidance. Participants can join via webcast or telephone, with pre-registration required for phone access. A replay will be available on the company's Investors page. This announcement suggests that Emergent BioSolutions is preparing to provide important financial information and future projections, which could potentially impact investor sentiment and stock performance.
Emergent BioSolutions Inc. (NYSE: EBS) ha annunciato che condurrà una conferenza telefonica il 6 agosto 2024 alle 17:00 ora orientale per discutere i suoi risultati finanziari del secondo trimestre 2024. La chiamata tratterà aggiornamenti chiave sull'andamento dell'azienda, previsioni di ricavi per il terzo trimestre del 2024 e linee guida per l'intero anno. I partecipanti possono unirsi tramite webcast o telefono, con registrazione anticipata necessaria per l'accesso telefonico. Una registrazione sarà disponibile nella pagina Investitori dell'azienda. Questo annuncio suggerisce che Emergent BioSolutions si sta preparando a fornire informazioni finanziarie importanti e proiezioni future, che potrebbero influenzare il sentiment degli investitori e le performance delle azioni.
Emergent BioSolutions Inc. (NYSE: EBS) ha anunciado que llevará a cabo una conferencia telefónica el 6 de agosto de 2024 a las 5:00 pm hora del este para discutir sus resultados financieros del segundo trimestre de 2024. La llamada cubrirá actualizaciones clave del negocio, pronósticos de ingresos para el tercer trimestre de 2024 y orientaciones para todo el año. Los participantes pueden unirse a través de un webcast o teléfono, siendo necesaria la preinscripción para acceder por teléfono. Una grabación estará disponible en la página de Inversores de la compañía. Este anuncio sugiere que Emergent BioSolutions se está preparando para ofrecer información financiera importante y proyecciones futuras, lo que podría impactar el sentimiento de los inversores y el rendimiento de las acciones.
Emergent BioSolutions Inc. (NYSE: EBS)는 2024년 8월 6일 동부 표준시 기준 오후 5시에 2024년 2분기 재무 결과를 논의하기 위한 전화 회의를 개최한다고 발표했습니다. 이 통화에서는 주요 비즈니스 업데이트, 2024년 3분기 수익 가이드라인 및 연간 가이드라인에 대해 논의할 예정입니다. 참가자는 웹캐스트 또는 전화로 참여할 수 있으며, 전화 접근을 위해 사전 등록이 필요합니다. 회사의 투자자 페이지에서는 재생 목록이 제공될 것입니다. 이 발표는 Emergent BioSolutions가 중요한 재무 정보와 미래 예측을 제공할 준비를 하고 있음을 나타내며, 이는 투자자 심리와 주식 성과에 영향을 미칠 수 있습니다.
Emergent BioSolutions Inc. (NYSE: EBS) a annoncé qu'elle tiendra une conférence téléphonique le 6 août 2024 à 17h00 heure de l'Est pour discuter de ses résultats financiers du deuxième trimestre 2024. L'appel portera sur des mises à jour clés de l'entreprise, des prévisions de revenus pour le troisième trimestre 2024 et des prévisions pour l'année entière. Les participants peuvent se joindre par webcast ou par téléphone, une pré-inscription étant nécessaire pour l'accès par téléphone. Un enregistrement sera disponible sur la page des Investisseurs de l'entreprise. Cette annonce suggère qu'Emergent BioSolutions se prépare à fournir des informations financières importantes et des projections futures, ce qui pourrait influencer le sentiment des investisseurs et la performance des actions.
Emergent BioSolutions Inc. (NYSE: EBS) hat angekündigt, am 6. August 2024 um 17:00 Uhr Eastern Time eine Telefonkonferenz abzuhalten, um über die Finanzergebnisse des zweiten Quartals 2024 zu sprechen. In dem Gespräch werden wichtige Unternehmensupdates, Umsatzprognosen für das dritte Quartal 2024 sowie die Jahresprognosen behandelt. Teilnehmer können über Webcast oder Telefon teilnehmen, wobei eine vorherige Registrierung für den Telefonzugang erforderlich ist. Eine Wiederholung wird auf der Investoren-Seite des Unternehmens verfügbar sein. Diese Ankündigung deutet darauf hin, dass Emergent BioSolutions sich darauf vorbereitet, wichtige Finanzinformationen und zukünftige Prognosen bereitzustellen, die das Anlegerverhalten und die Aktienperformance potenziell beeinflussen könnten.
- Providing forward-looking guidance for Q3 2024 and full year
- Offering multiple access options for the earnings call, enhancing investor accessibility
- None.
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of 2024, as well as full year guidance.
Conference Call Information
Participants can access the conference call live via webcast. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
FAQ
When will Emergent BioSolutions (EBS) release its Q2 2024 financial results?
What topics will be covered in Emergent BioSolutions' (EBS) Q2 2024 earnings call?
How can investors participate in Emergent BioSolutions' (EBS) Q2 2024 earnings call?
Will there be a replay available for Emergent BioSolutions' (EBS) Q2 2024 earnings call?
